Literature DB >> 12539553

The study on the relationship between serum vascular endothelial growth factor and proteinuria in adriamycin-induced nephrotic rats.

Z Zhu1, Y Wang, H Wang, A Deng.   

Abstract

To study the relationship between serum vascular endothelial growth factor (VEGF) and proteinuria in adriamycin-induced nephrotic rats, a rat model of adriamycin-induced nephrotitis was developed by injection of adriamycin into a tail vein in a rat. At different time points, 24-h urinary protein excretion was measured by using Coomassie brilliant blue method and the serum VEGF levels detected by using ELISA assay. The interventional effect of VEGF on this model was observed. The results showed that: (1) The adriamycin-induced nephrotic syndrome rat model was developed successfully; (2) Serum VEGF levels and proteinuria were significantly increased at 7th day after intravenous injection of adriamycin. There was a positive correlation between serum VEGF levels and 24-h urinary protein excretion (r = 0.67, P < 0.05). (3) The 24-h urinary protein excretion was significantly increased in the rats receiving administration of VEGF (P < 0.05). It was concluded that VEGF might play an important role in the pathogenesis of proteinuria in adriamycin-induced nephrotic rats.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12539553     DOI: 10.1007/BF02886562

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  7 in total

Review 1.  Molecular analysis of blood vessel formation and disease.

Authors:  P Carmeliet; D Collen
Journal:  Am J Physiol       Date:  1997-11

2.  Vascular endothelial growth factor mRNA expression in minimal change, membranous, and diabetic nephropathy demonstrated by non-isotopic in situ hybridisation.

Authors:  E Bailey; M J Bottomley; S Westwell; J H Pringle; P N Furness; J Feehally; P E Brenchley; S J Harper
Journal:  J Clin Pathol       Date:  1999-10       Impact factor: 3.411

3.  Circulating vascular endothelial growth factor is not increased during relapses of steroid-sensitive nephrotic syndrome.

Authors:  N J Webb; C J Watson; I S Roberts; M J Bottomley; C A Jones; M A Lewis; R J Postlethwaite; P E Brenchley
Journal:  Kidney Int       Date:  1999-03       Impact factor: 10.612

4.  Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents.

Authors:  J M Gleadle; B L Ebert; J D Firth; P J Ratcliffe
Journal:  Am J Physiol       Date:  1995-06

5.  Glomerular endothelial cells in culture express and secrete vascular endothelial growth factor.

Authors:  K Uchida; S Uchida; K Nitta; W Yumura; F Marumo; H Nihei
Journal:  Am J Physiol       Date:  1994-01

6.  Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases.

Authors:  K Shulman; S Rosen; K Tognazzi; E J Manseau; L F Brown
Journal:  J Am Soc Nephrol       Date:  1996-05       Impact factor: 10.121

7.  Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney.

Authors:  M Simon; H J Gröne; O Jöhren; J Kullmer; K H Plate; W Risau; E Fuchs
Journal:  Am J Physiol       Date:  1995-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.